Perrigo Company plc (PRGO)

CIK 0001585364 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest 8-K (2026-08-05) · 99.1
Q1-2026 8-K (2026-05-06) · 99.1  |  8-K (2026-04-22) · 99.1
Latest FY-2025 8-K (2026-02-26) · 99.1
Q3-2025 8-K (2025-11-05) · 99.1 · 99.2
Q2-2025 8-K (2025-08-06) · 99.1
Q1-2025 8-K (2025-05-07) · 99.1
FY-2024 8-K (2025-02-27) · 99.1
Q3-2024 8-K (2024-11-06) · 99.1
Q2-2024 8-K (2024-08-02) · 99.1
Q1-2024 8-K (2024-05-07) · 99.1
FY-2023 8-K (2024-02-27) · 99.1
Q3-2023 8-K (2023-11-07) · 99.1
Q2-2023 8-K (2023-08-08) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Consolidated Statements of Operations
Condensed Consolidated Statements of Comprehensive Income
—
Consolidated Statements of Comprehensive Income (loss)
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Shareholders Equity
Consolidated Statements of Comprehensive Income (loss) (P)
—
Consolidated Statements of Shareholders Equity (P)
Consolidated Statements of Cash Flows
Notes
Accumulated Other Comprehensive Income (loss)
Acquisitions and Divestitures
Assets Held For Sale
Commitments and Contingencies
Contingencies
—
Cybersecurity Risk Management and Strategy Disclosure
—
Derivative Instruments and Hedging Activities
Discontinued Operations
Divestitures
Divestitures and Acquisitions
—
Earnings Per Share and Shareholders' Equity
Fair Value Measurements
Goodwill and Intangible Assets
Income Taxes
Indebtedness
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventories
Investments
Leases
Pay Vs Performance Disclosure
Post-employment Plans
—
Property, Plant and Equipment, Net
—
Restructuring Charges
Revenue Recognition
Segment and Geographic Information
Segment Information
—
Share-based Compensation Plans
—
Subsequent Events
Summary of Significant Accounting Policies